Skip to content

Dual-Action Recombinant Vesicular Stomatitis Virus (rVSV)-Based Vaccine Against COVID-19 and Influenza Viruses

A bivalent VSV vaccine against COVID-19 Delta Variant and Influenza Virus

Published: 31st May 2022
Dual-Action Recombinant Vesicular Stomatitis Virus (rVSV)-Based Vaccine Against COVID-19 and Influenza Viruses
Production Perig, https://stock.adobe.com/uk/332851313, stock.adobe.com
Patents
  • US Provisional Application 63/236455
IP Status
  • Patent application submitted
Seeking
  • Development partner
  • Commercial partner
  • Licensing